deltatrials
Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT03113968

ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD) (ELEKT-D)

Sponsor: Bo Hu

Conditions Depression ECT Electroconvulsive Therapy Ketamine Major Depressive Disorder Major Depressive Episode Psychiatric Disorder Treatment Resistant Depression Unipolar Depression
Interventions Ketamine electroconvulsive therapy (ECT)
Updated 19 times since 2017 Last updated: Sep 1, 2023 Started: Apr 7, 2017 Primary completion: Oct 28, 2022 Completion: Nov 17, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Depression and ECT, this trial is completed. The trial is conducted by Bo Hu and has accumulated 19 data snapshots since 2017. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

~May 2017 – ~Jun 2017 · 31 days · monthly snapshot~Jun 2017 – ~Aug 2017 · 2 months · monthly snapshot~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Sep 2018 · 2 months · monthly snapshot~Sep 2018 – ~Nov 2018 · 2 months · monthly snapshot~Nov 2018 – ~Jul 2019 · 8 months · monthly snapshot~Jul 2019 – ~May 2020 · 10 months · monthly snapshot~May 2020 – ~Jul 2020 · 2 months · monthly snapshot~Jul 2020 – ~Oct 2020 · 3 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Apr 2022 · 7 months · monthly snapshot~Apr 2022 – ~Nov 2022 · 7 months · monthly snapshot~Nov 2022 – ~Sep 2023 · 10 months · monthly snapshot~Sep 2023 – ~Oct 2023 · 30 days · monthly snapshot~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

19 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  3. Oct 2023 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

    Status: Active Not Recruiting → Completed

  4. Sep 2023 — Oct 2023 [monthly]

    Active Not Recruiting PHASE2_PHASE3

    Status: Recruiting → Active Not Recruiting

  5. Nov 2022 — Sep 2023 [monthly]

    Recruiting PHASE2_PHASE3

▶ Show 14 earlier versions

  1. Apr 2022 — Nov 2022 [monthly]

    Recruiting PHASE2_PHASE3

  2. Sep 2021 — Apr 2022 [monthly]

    Recruiting PHASE2_PHASE3

  3. Jan 2021 — Sep 2021 [monthly]

    Recruiting PHASE2_PHASE3

  4. Oct 2020 — Jan 2021 [monthly]

    Recruiting PHASE2_PHASE3

    Status: Active Not Recruiting → Recruiting

  5. Jul 2020 — Oct 2020 [monthly]

    Active Not Recruiting PHASE2_PHASE3

  6. May 2020 — Jul 2020 [monthly]

    Active Not Recruiting PHASE2_PHASE3

    Status: Recruiting → Active Not Recruiting

  7. Jul 2019 — May 2020 [monthly]

    Recruiting PHASE2_PHASE3

  8. Nov 2018 — Jul 2019 [monthly]

    Recruiting PHASE2_PHASE3

  9. Sep 2018 — Nov 2018 [monthly]

    Recruiting PHASE2_PHASE3

  10. Jul 2018 — Sep 2018 [monthly]

    Recruiting PHASE2_PHASE3

  11. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE2_PHASE3

  12. Aug 2017 — Jun 2018 [monthly]

    Recruiting PHASE2_PHASE3

  13. Jun 2017 — Aug 2017 [monthly]

    Recruiting PHASE2_PHASE3

  14. May 2017 — Jun 2017 [monthly]

    Recruiting PHASE2_PHASE3

    First recorded

Apr 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bo Hu
  • Patient-Centered Outcomes Research Institute
Data source: The Cleveland Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations